Quantbot Technologies LP Acquires New Position in Aspen Aerogels, Inc. $ASPN

Quantbot Technologies LP bought a new position in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) in the third quarter, HoldingsChannel reports. The fund bought 158,583 shares of the construction company’s stock, valued at approximately $1,104,000.

Other institutional investors also recently modified their holdings of the company. Nisa Investment Advisors LLC grew its holdings in shares of Aspen Aerogels by 1,094.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock valued at $28,000 after acquiring an additional 4,390 shares in the last quarter. SBI Securities Co. Ltd. raised its holdings in shares of Aspen Aerogels by 67.3% during the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after acquiring an additional 2,551 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in shares of Aspen Aerogels during the first quarter worth $43,000. Tower Research Capital LLC TRC boosted its position in Aspen Aerogels by 184.6% during the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after purchasing an additional 4,693 shares during the last quarter. Finally, Olympiad Research LP acquired a new stake in Aspen Aerogels during the third quarter valued at $70,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Trading Down 1.5%

Aspen Aerogels stock opened at $3.22 on Friday. Aspen Aerogels, Inc. has a one year low of $2.30 and a one year high of $9.78. The company’s fifty day moving average price is $3.36 and its two-hundred day moving average price is $4.91. The company has a market capitalization of $266.13 million, a price-to-earnings ratio of -0.68 and a beta of 2.99. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its quarterly earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.07). Aspen Aerogels had a negative return on equity of 13.07% and a negative net margin of 143.69%.The company had revenue of $41.34 million for the quarter, compared to the consensus estimate of $44.25 million. During the same quarter last year, the company posted $0.14 EPS. The business’s revenue was down 66.4% compared to the same quarter last year. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

ASPN has been the topic of several research reports. TD Cowen dropped their target price on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Roth Mkm reduced their price target on Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Canaccord Genuity Group lowered their price target on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, November 7th. Zacks Research upgraded Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, December 29th. Three equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $4.25.

Check Out Our Latest Stock Analysis on Aspen Aerogels

About Aspen Aerogels

(Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

Recommended Stories

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.